BE584914A - - Google Patents

Info

Publication number
BE584914A
BE584914A BE584914DA BE584914A BE 584914 A BE584914 A BE 584914A BE 584914D A BE584914D A BE 584914DA BE 584914 A BE584914 A BE 584914A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of BE584914A publication Critical patent/BE584914A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE584914D 1958-11-24 BE584914A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US775719A US3023235A (en) 1958-11-24 1958-11-24 New amino acids and derivatives thereof

Publications (1)

Publication Number Publication Date
BE584914A true BE584914A (en:Method)

Family

ID=25105269

Family Applications (1)

Application Number Title Priority Date Filing Date
BE584914D BE584914A (en:Method) 1958-11-24

Country Status (5)

Country Link
US (1) US3023235A (en:Method)
BE (1) BE584914A (en:Method)
ES (2) ES253663A1 (en:Method)
FR (2) FR1309811A (en:Method)
GB (1) GB917435A (en:Method)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE638485A (en:Method) * 1962-10-11
US3505385A (en) * 1962-10-11 1970-04-07 Merck & Co Inc Alpha-lower alkanoylamino - alpha - hydroxy and/or methoxy substituted benzyl propionitriles
CH441362A (de) * 1963-12-24 1967-08-15 Hoffmann La Roche Verfahren zur Herstellung von Phenylalaninderivaten
US4070478A (en) * 1977-02-17 1978-01-24 Merck & Co., Inc. Benzimidazole substituted alanines
US4271187A (en) * 1978-06-05 1981-06-02 Merck & Co., Inc. Substituted phenyl alanine antihypertensive agents
ZA794723B (en) * 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
US4421767A (en) * 1981-06-01 1983-12-20 Merrell Toraude Et Compagnie Compounds and methods for treating depression
US5238958A (en) * 1990-02-26 1993-08-24 Warner-Lambert Company Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds
GB9402809D0 (en) * 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
US6229011B1 (en) * 1997-08-22 2001-05-08 Hoffman-La Roche Inc. N-aroylphenylalanine derivative VCAM-1 inhibitors
MXPA01008178A (es) 1999-02-18 2002-03-13 Hoffmann La Roche Derivados de fenilalaninol.
KR100649819B1 (ko) 1999-02-18 2007-02-28 에프. 호프만-라 로슈 아게 티오아미드 유도체
MXPA03003868A (es) 2000-10-30 2003-07-28 Janssen Pharmaceutica Nv Inhibidores de tripeptidil peptidasa.
US7041681B2 (en) * 2002-04-29 2006-05-09 Janssen Pharmaceutica N.V. Compounds as opioid receptor modulators
US7022872B2 (en) * 2003-12-19 2006-04-04 Molecular Technologies, Inc. Method for making fluorine labeled L-Dopa

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2833810A (en) * 1956-03-05 1958-05-06 American Cyanamid Co O-alkyltyrosine esters

Also Published As

Publication number Publication date
FR555M (en:Method) 1961-05-29
US3023235A (en) 1962-02-27
ES253663A1 (es) 1960-06-01
FR1309811A (fr) 1962-11-23
GB917435A (en) 1963-02-06
ES253662A1 (es) 1960-06-16

Similar Documents

Publication Publication Date Title
FI40362B (en:Method)
FR555M (en:Method)
FI48726B (en:Method)
AT214638B (en:Method)
BE586036A (en:Method)
AT215747B (en:Method)
AT213446B (en:Method)
AT213908B (en:Method)
AT215751B (en:Method)
IT617528A (en:Method)
AT213472B (en:Method)
AT214270B (en:Method)
AT216771B (en:Method)
AT219815B (en:Method)
AT215738B (en:Method)
AT216612B (en:Method)
AT213313B (en:Method)
DE1129985C2 (en:Method)
AT216803B (en:Method)
AT216749B (en:Method)
AT213557B (en:Method)
AT219868B (en:Method)
AT213631B (en:Method)
JPS411649B1 (en:Method)
BE568293A (en:Method)